The author shows that while traditional pharmaceutical companies have successfully adjusted their business models to meet the challenges of biotechnology, biopharmaceutical start-ups have experienced more problems. Despite the poor financial performance of the vast majority of these firms, the biopharmaceutical sector as a whole has created significant value. However, this has been captured disproportionately by a handful of large, fully-integrated biopharmaceutical firms and, to a lesser extent, by the largest dozen pharmaceutical companies.
This highly focused book will be a captivating read for innovation and biopharmaceutical industry analysts, as well as advisers formulating policies to support the development of the biopharmaceutical sector. Academics working on innovation and biotechnology, as well as scientists engaged in research in the life sciences, will also find this book of particular interest.
You can read this ebook online in a web browser, without downloading anything or installing software.
This ebook is available in file types:
This ebook is available in:
After you've bought this ebook, you can choose to download either the PDF version or the ePub, or both.
The publisher has supplied this book in DRM Free form with digital watermarking.
You can read this eBook on any device that supports DRM-free EPUB or DRM-free PDF format.
The publisher has supplied this book in encrypted form, which means that you need to install free software in order to unlock and read it.
To read this ebook on a mobile device (phone or tablet) you'll need to install one of these free apps:
To download and read this eBook on a PC or Mac:
The publisher has set limits on how much of this ebook you may print or copy. See details.